TRIB
Trinity Biotech
TRIB
TRIB
27 hedge funds and large institutions have $15.9M invested in Trinity Biotech in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.31% less ownership
Funds ownership: 1.83% → 1.51% (-0.31%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Holders
27
Holding in Top 10
–
Calls
$661K
Puts
$26K
Top Buyers
| 1 | +$1.53M | |
| 2 | +$373K | |
| 3 | +$291K | |
| 4 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$234K |
| 5 |
Goldman Sachs
New York
|
+$130K |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$1.3M | |
| 3 | -$580K | |
| 4 |
FM
Fondren Management
Houston,
Texas
|
-$253K |
| 5 |
Millennium Management
New York
|
-$120K |